Previous studies have demonstrated that combining 3-MA with cell division-related agents, such as paclitaxel or polo-like kinase 1 (PLK1) inhibitors, enhances cytotoxicity in NPC cells [12]. Here, PLK1 is linked to nasopharyngeal carcinoma.